Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 37Head and Neck Neoplasms 28Prostatic Neoplasms 16Oropharyngeal Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Gliosarcoma 8Glioblastoma 8Carcinoma, Squamous Cell 7Brain Neoplasms 7Tongue Neoplasms 6Rectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Laryngeal Neoplasms 5Astrocytoma 5Papillomavirus Infections 4Neoplasm Metastasis 4Mouth Neoplasms 4Sarcoma 3Neoplasms 3Hypopharyngeal Neoplasms 3Glioma 3Carcinoma 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Stomatitis 2Rhabdomyosarcoma 2Radiation Injuries 2

Interventions

Taxes 5Paclitaxel 5Carboplatin 4Immunoglobulin G 2Disulfides 2Cisplatin 2Bevacizumab 2temsirolimus 1pegfilgrastim 1nintedanib 1ixabepilone 1cediranib 1brivanib 1Sunitinib 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Platinum 1Metformin 1Medroxyprogesterone Acetate 1Medroxyprogesterone 1MK 2206 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Epothilones 1Doxorubicin 1Brachytherapy 1AZD 6244 1ALK1-Fc fusion protein, human 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Endometrial Adenocarcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT01005329 2018-03-15

Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
34 enrolled 10 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡